This clinical trial is focused on studying two eye conditions: Chronic Open-angle Glaucoma and Ocular Hypertension. These conditions involve increased pressure in the eye, which can lead to vision problems if not managed properly. The study will compare two treatments: a preservative-free version of Bimatoprost eye drops, known by the code name BIM-001, and a reference product called Lumigan, which also contains Bimatoprost. Both treatments are designed to help lower the pressure inside the eye.
The purpose of this study is to evaluate how effective, safe, and tolerable these treatments are for patients with the mentioned eye conditions. Participants will be randomly assigned to one of the two treatment groups. The study will last for a period of 42 days, during which participants will use the eye drops as directed. Throughout the study, the pressure in the eyes will be monitored, and any side effects or changes in eye health will be recorded.
Participants will visit the study center several times to have their eye pressure checked and to discuss any changes in their condition. The study aims to determine which treatment is more effective in reducing eye pressure and how well patients tolerate each treatment. This information will help doctors make better treatment decisions for people with Chronic Open-angle Glaucoma or Ocular Hypertension.



Italy